BPA Makes Little Girls Anxious and Depressed

Illustration: Christoph Hitz

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


A new study shows that girls who were exposed to chemical bisphenol-A (BPA) as fetuses are more highly prone to hyperactive, anxious, aggressive, and depressed behavior than boys of similar age. BPA, an estrogen-mimicking chemical used to harden plastic, is found in consumer products ranging widely from canned soups to baby bottles and grocery receipts. (MoJo‘s Kiera Butler’s got the full rundown on BPA’s health risks.)

The study, published Monday in the journal Pediatrics, joins a mounting body of evidence linking BPA to various reproductive and developmental diseases. The study’s authors tested urine samples of 244 mothers during pregnancy and at birth and of their children for the first three years. The urine tests showed BPA in 84 percent of the women’s samples and in 96 percent of the children’s, with indications that behavior problems in the girls rose with rising BPA levels. But while the study shows a strong correlation between behavioral change and BPA levels, its authors say more research is needed.

Meanwhile, other studies in recent years have linked BPA exposure to impaired thyroids, obesity, diabetes, heart disease, breast and prostate cancer, and infertility in both men and women. The Pediatrics study confirms two previous ones finding that prenatal exposure to BPA affects child behavior, and it’s the first to demonstrate that BPA exposure prebirth may matter more than exposure postbirth, lead author Joe Braun told Bloomberg.

The growing case against BPA has motivated an increasing number of state legislators to ban the substance from certain consumer products. Earlier this month, California officially banned BPA from baby bottles and sippy cups, joining 10 other states that have recently passed similar bills. Around the world, BPA is already outlawed in the European Union, Canada, China, the United Arab Emirates, and Malaysia.

The Food and Drug Administration, which oversees federal regulation over chemicals in the United States, does not support a ban on BPA. This, despite being heavily criticized by consumer advocacy groups and being sued for failing “to safeguard the food supply.” In 2009 the Consumers Union warned of the health risks posed by BPA in food containers, basing its position on more than 200 different scientific studies. The FDA recognizes that the recent studies on BPA warrant reason for “some concern.” But it ultimately argues that there are “substantial uncertainties” in the interpretation of the studies and says it is conducting its own research on the matter.

Marion Nestle, a nutrition, food, and public health professor at New York University, sums up the regulatory BPA debate neatly:

In the absence of compelling science, regulators have two choices: exercise the “precautionary principle” and ban [BPA] until it can be proven safe, or approve it until it can be shown to be harmful. The United States and European safety agencies—and the food industry, of course—prefer the latter approach.

It’s not just about the science. Unsurprisingly, plastic and other industry lobbyists routinely call into question the methodology of studies condemning BPA use, as they did in this most recent case. The criticism makes sense given that industry groups have also been campaigning aggressively against state legislation banning BPA from certain consumer products. In California alone, the American Chemical Council (ACC) spent $9.4 million on lobbying since 2005, Greenwire reported earlier this month. And the money can be persuasive. Mother Jones reported last month that the Susan G. Komen foundation, a leading breast cancer research group, downplayed BPA’s links to cancer around the time it was receiving funding from pro-BPA pharma companies.

Now that states are starting to move toward BPA bans despite industry opposition, groups like the ACC seem to be stepping up their game, making a new push for the FDA to have final say over BPA regulation. Of course, if federal jurisdiction were to override the emerging state-level bans, the FDA’s inconclusive position on BPA as a public health threat would work well in the industry’s favor.

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate